Visiomed Group SA

Equities

ALVMG

FR0013481835

Medical Equipment, Supplies & Distribution

Real-time Euronext Paris Other stock markets 05:43:41 2024-04-25 am EDT			5-day change	1st Jan Change
0.1924 ^EUR	+2.67%		+0.31%	-32.01%

Mar. 26	Visiomed: share price rises on 'record' 2023 results	CF
Feb. 13	Visiomed: 38% increase in annual sales	CF

Medical Intelligence Service SAS announced that it has received €0.85 million in funding from Visiomed Group SA and other investors

July 07, 2021

Medical Intelligence Service announced that it has issued common stock for €850,000 in a round of funding on July 8, 2021. The transaction will include participation from returning investor Visiomed Group SA. for €100,000 and other new shareholders for €750,000. Post the transaction, Visiomed Group SA. will hold 24% stake in the company. The round is raised at the post money valuation of €6,000,000.

Latest news about Visiomed Group SA

Visiomed: share price rises on 'record' 2023 results	Mar. 26	CF
Visiomed: 38% increase in annual sales	Feb. 13	CF
Visiomed: new CEO appointed	Jan. 22	CF
Visiomed: expands activities in Saudi Arabia	Jan. 02	CF
Visiomed Group Secures Location for Plan to Build Medical Center in Saudi Arabia	Jan. 02	MT
Visiomed Group SA's Equity Buyback announced on April 17, 2023, has expired.	23-10-18	CI
Visiomed Group SA Reports Earnings Results for the Half Year Ended June 30, 2023	23-10-09	CI
CAC40: ends the day in green despite bond tensions	23-08-21	CF
CAC40: rebound falters, rising interest rates cause concern	23-08-21	CF
CAC40: back above 7,200 despite glowing interest rates	23-08-21	CF
CAC40: starts the week in green, tops 7200 points	23-08-21	CF
Visiomed: share price rises sharply on resumption of trading	23-08-21	CF
CAC40: erases part of its losses before the close	23-08-18	CF
CAC40: decline confirmed, stagnates above 7100 pts	23-08-18	CF
CAC40: at 7100 points, the downturn deepens	23-08-18	CF
Visiomed: listing suspended	23-08-18	CF
VISIOMED : EuroLand Corporate initiates Buy coverage	23-06-08	CF
Visiomed Group SA Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-26	CI
Visiomed Commences EUR44 Million Share Repurchase Program	23-04-24	MT
Visiomed: launch of share buyback program, share price surges	23-04-18	CF
Visiomed Group SA announces an Equity Buyback for 29,435,641 shares, representing 10% for €44.15 million.	23-04-16	CI
Visiomed Group SA authorizes a Buyback Plan.	23-04-16	CI
Visiomed Group: 3rd digital medical center in Dubai	23-03-09	CF
Visiomed Group to Form Healthcare JV in Saudi Arabia	23-02-17	MT
Visiomed: partnership to establish a presence in Saudi Arabia	23-02-17	CF

Chart Visiomed Group SA

Duration

Period

More charts

Company Profile

Founded in 2007, Visiomed Group SA relies on a long experience to innovative healthcare technologies and services that will shape tomorrow's health and prevention. The Group now has focused its activities on the Middle East since 2021 with the acquisition of Smart Salem, the first digital medical analysis centre accredited by the Dubai Health Authority (DHA) in the United Arab Emirates, 100% owned by Visiomed Group SA. Visiomed Group SA is also stepping up its development in the region, with the creation of Smart Health, a joint venture which will drive the deployment of the group's innovative centers in Saudi Arabia.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
VISIOMED GROUP SA	-32.01%	58.93M
ABBOTT LABORATORIES	-2.89%	185B
MEDTRONIC PLC	-2.43%	107B
BECTON, DICKINSON AND COMPANY	-4.10%	67.55B
DEXCOM, INC.	+11.10%	54.6B
CENCORA, INC.	+15.86%	47.42B
HOYA CORPORATION	+3.86%	42.24B
WEST PHARMACEUTICAL SERVICES, INC.	+9.55%	28.24B
METTLER-TOLEDO INTERNATIONAL, INC.	+1.85%	26.42B
TERUMO CORPORATION	+12.40%	25.66B

Other Medical Equipment, Supplies & Distribution